CELANESE CORPORATION
At today's price, CELANESE CORPORATION (CE) is priced for +7.4% growth. boothcheck doesn't publish a fair value or a price target; it shows what the price assumes, so you can judge whether that bar is too high. Built from SEC EDGAR filings.
Celanese is a cyclical chemicals business at a trough, so the numbers have to be read through the cycle, not at the bottom. Trailing operating income is negative, so the inversion normalizes to through-cycle margins: at $51.18 the price pays about 27x mid-cycle operating income, implying roughly 8.1% operating-profit growth for five years. The price is supported by the earnings-power, relative-multiple, and growth-DCF families (relative valuation near $129, perpetual-growth DCF near $117, Earni
Is CE overvalued? See what's priced in →
452 institutional managers reported holding CE in 13F filings for the quarter ended 2026-03-31. 112 opened new positions that quarter. Held by Dodge & Cox, BlackRock, Vanguard Group, among others. On the short side, 7.5M shares were sold short as of the 2026-06-15 count, about 7% of shares outstanding (4.7 days of typical volume to cover).
Quarterly 13F filings arrive up to 45 days after quarter end, so the picture is never current (filed through 2026-05-29). Nothing here is investment advice.
CE has cut its share count 2.3% over the past five years, spending $500.00M on repurchases. It pays a dividend, and has paid one every year in our records (18 and counting). Cash returned over the past three years: $476.00M in dividends.
Share counts are split-adjusted; repurchase totals are gross of share issuance. Nothing here is investment advice.
Open-market insider buys at CE over the trailing three years: 2024: 2 buys totaling $313k; 2025: 14 buys totaling $1.49M. 18 officers and directors are on file.
Code P open-market purchases from SEC Form 4 filings, non-derivative, excluding scheduled 10b5-1 plans. Nothing here is investment advice.
CE's recent reports: the day-one move, then what the following quarter actually did.
| report | day one | next quarter |
|---|---|---|
| 2023-08-09 | +1.1% | -1.7% |
| 2023-11-09 | -3.6% | +26.6% |
| 2024-02-24 | -0.5% | +3.4% |
| 2024-05-11 | -0.8% | -9.2% |
Day-one is the close-to-close move around the filing. Nothing here is investment advice.
CE's latest 8-K filings: 2026-06-10 (items 8.01); 2026-05-05 (items 7.01, 9.01); 2026-05-05 (items 2.02, 9.01); 2026-04-20 (items 5.02, 9.01); 2026-04-17 (items 5.07, 9.01).
Item codes are the SEC's own classification of what each report discloses. Nothing here is investment advice.
Last analyzed: June 27, 2026
Each week boothcheck ranks the stocks whose prices are betting on the most. Read the most stretched bets archive →
boothcheck is also on Android. Get the app on Google Play →
For informational and research purposes only. Not investment advice. Not a recommendation to buy, sell, or hold any security. boothcheck is not a registered investment adviser. Past performance does not guarantee future results.